| Identification | Back Directory | [Name]
Research Grade Ulviprubart (DHK27701) | [CAS]
2569434-60-0 | [Synonyms]
Ulviprubart
Research Grade Ulviprubart
Research Grade Ulviprubart (DHK27701) |
| Hazard Information | Back Directory | [Uses]
Ulviprubart (ABC-008) is a monoclonal antibody targeting the KLRG1 receptor that selectively depletes highly differentiated cytotoxic T cells. Ulviprubart can be used in the study of inclusion body myositis (IBM)[1]. | [References]
[1] Brady S, et al. Inclusion body myositis: Correcting mitochondfrial and lysosomal autophagy impairment as a potential therapeutic strategy[J]. Autoimmunity Reviews, 2024: 103644. DOI:10.1016/j.autrev.2024.103644
[2] Konry T, et al., Single Cell Droplet-Based Efficacy and Transcriptomic Analysis of a Novel Anti-KLRG1 Antibody for Elimination of Autoreactive T Cells. Res Sq [Preprint]. 2024 Sep 8:rs.3.rs-4745216. DOI:10.21203/rs.3.rs-4745216/v1 |
|
| Company Name: |
Biolab Reagents
|
| Telephone: |
027-65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
TargetMol
|
| Telephone: |
400-821-0310 15002144251 |
| Website: |
www.targetmol.cn/ |
|